LenioBio GmbH

LenioBio GmbH is a privately held, life sciences company focused on developing protein expression platforms that will transform the way companies produce their proteins of choice. Our aim is to establish a leadership position in the protein expression arena by offering cell free solutions that deliver unprecedented performance and ease of use.

LenioBio’s first product, ALiCE, is a cell-free protein expression kit, which will offer our customers higher protein yields in a single step than any other cell free expression system currently available. ALiCETM has served as one the cornerstone technologies in the crop development of Dow AgroSciences and is the result of the development efforts of LenioBio and its partners Dow AgroSciences (US), and Fraunhofer IME (Germany). 

www.leniobio.com